Category Archives: Events

Latest From Events

BIO India Hosts Biopharmaceutical Regulatory and Policy Roundtable

bio-india-btn

During last week’s BIO India International Conference, BIO, in partnership with the Association of Biotech-Led Enterprises (ABLE) and the Confederation of Indian Industries (CII) held a roundtable to discuss ways that U.S. and Indian industry can work together to facilitate the development of new biotechnology products and commercialization. Participants in the roundtable represented U.S. and Indian industry, academia, and government and shared their views on critical issues important to the development of the Indian biotechnology Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Award Honors Rhode Island Biotech Excellence

RI_imagelogo

Know somebody in Rhode Island biotech that deserves special recognition? Then nominate them for Tech Collective’s Rhode Island Bioscience Awards. Check it out, nominate, and apply here. Nominations are due September 24th, Applications are due October 1st.

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , ,

Jim Greenwood Shares his Thoughts on BIO India

Jim Greenwood

As a non-profit trade association that represents the biotech industry, BIO is pleased to bring the BIO International Conference back to India in an effort to further create and drive business development and collaborations between the US and Indian industry in all areas relating to biotechnology. The conference, which will be held in Mumbai this year on September 12-13, brings together global business and thought leaders in the various areas of biotechnology for partnering. For Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , ,

BioSpectrum Asia Survey Shows Promising Results for the Biosciences Industry

India2012_Thumbnail

BioSpectrum Asia recently completed a survey of close to 500 bioscience companies listed on different stock exchanges in both the Asia Pacific region (APAC) and in American stock exchanges, with total revenue of $139 billion (year end 2011) and market capitalization of $200 billion. The survey says of the top 20 companies in the region, comprising mostly of pharmaceutical, biotechnology and medical technology companies and focusing on R&D, manufacturing and marketing of life sciences products, Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,

2012 BIO Investor Forum: Looking Ahead to Investment Opportunities

partnering1

The biggest biotech news out of Washington in recent months was the Jumpstart Our Business Startups (JOBS) Act, which passed Congress overwhelmingly and was signed into law by President Obama in April.  For those not familiar, the JOBS Act creates a new category of issuers, called “emerging growth companies” (EGCs), which is defined as newly public companies with than $1 billion in annual revenues and a public float below $700 million. EGCs are given a Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , ,